European Parliament reprimands food advisory body for industry links.
Three European agencies are fighting to rebut charges that they enjoy
an overly cosy relationship with companies and interest groups.
Read article on the Nature science journal website
Friday, May 25, 2012
EU agencies and conflicts of interest
Posted by
Willow
at
11:28 am
Labels: conflicts of interest, EFSA, EU, European Food Safety Authority, European Parliament
Wednesday, May 02, 2012
For a new perspective on conflicts of interest with regard to the pharmaceutical industry and health campaigning charities
For a new perspective on conflicts of interest with regard to the
pharmaceutical industry and health campaigning charities I invite you to
put the name of one such charity and the words "pharmaceutical
sponsors" into your favourite search engine's searchbox. - I typed
asthma.org.uk pharmaceutical sponsors
into my searchbox and I was led to a page about a publication by The Stationery Office, viz.
The Influence of the Pharmaceutical Industry: Fourth Report of Session 2004-05
By Great Britain: Parliament: House of Commons: Health Committee, Health Committee Parliament Great Britain House of Commons.Whoever the actual people were who wrote this publication, they were clearly aware that the drug industry's sponsorship of charities is not motivated by philanthropy, but by greed, in the hope and expectation of increasing the sales of their drugs, and thereby increasing their profits. You may draw your own conclusions from that, as I do mine. It leads me to conclude that the advice given on the websites and in the literature of some at least of the major health campaigning charities, such as AsthmaUK, DiabetesUK, British Heart Foundation and others, may not really be in the best interests of the patients/sufferers they ostensibly serve. I hold in mind that we are constantly assured that business companies must act in the interests of their share-holders. So if I wanted to help people suffering from asthma, I personally would advise them to cut down on salt and salty food as this would improve their health in many ways. It would reduce excess fluid retention and thereby reduce excess weight, one of the risk factors for asthma, It would reduce high blood pressure if they had high blood pressure. It would reduce breathing problems. - And very importantly, if they had gained a lot of weight from using prescribed steroids for their asthma symptoms, it would speedily reduce that weight gain and the other serious adverse effects of prescribed steroids.(See my webpage about prescribed steroids.) What I would definitely not do is donate to AsthmaUK... - I don't donate to drug company profits.
Posted by
Willow
at
10:07 pm
Labels: Asthma, AsthmaUK, Big Pharma, British Heart Foundation, conflicts of interest, cut down on salt and salty food, Diabetes UK, drug industry, health campaigning charities, Pharmaceutical industry
Friday, March 23, 2012
Conflicts of Interest on Stilts - or is it on Steroids?
Conflicts of Interest on Stilts - or is it Steroids? - Read George Monbiot's Guardian article. "Democracy itself is being undermined by publicly funded agencies crawling with conflicts of interest and devoid of scrutiny" I urge you to read the whole of this excellent article about how undue power is increasingly being accorded to Big Pharma and other industrial giants, while ordinary voters and other taxpayers go unrepresented on these quangos.
And here is some of what Dr Rath has to say about this: "At the time of writing, the Board of Britain’s Medicines and Healthcare Products Regulatory Agency (MHRA) contains retired senior executives from drug companies AstraZeneca and Merck Sharp & Dohme. Similarly, its Executive Board contains a former employee of Glaxo, DuPont and DuPont Pharmaceuticals who is currently an employee of Bristol-Myers Squibb; a former employee of Glaxo Wellcome and GlaxoSmithKline; and a former employee of SmithKline Beecham. Continuing this pattern, the council members on the country’s Medical Research Council (MRC) include representatives of Sanofi Pasteur and Pfizer, whilst its Global Health Group and Translational Research Group both have members from GlaxoSmithKline."
Posted by
Willow
at
10:10 pm
Labels: AstraZeneca, conflicts of interest, drug companies, George Monbiot, Glaxo, Guardian article, KPMG, Medical Research Council, MHRA, NHS
Tuesday, December 20, 2011
Freudian Slip by the Department of Health
Freudian Slip by the Dept of Health: see the Guardian article Matthew Freud picks up £1m-a-year contract with Department of Health. The contract is intended to improve public health, e.g. reduce obesity.
Freud is a PR guy whose agency (Freud Communications) works for clients that include Pepsi, KFC, Walkers Crisps and the premium drinks company, Diageo. They are companies whose products could never be accused of being remotely good for public health. And remember Change4Life? - Freud handled that anti-obesity campaign, notable for its spectacular lack of success in reducing the nation's growing obesity problem. Well if Freud and his company have as little success at improving public health as they have so far demonstrated, at least their other clients will feel the benefit in their swelling profits. - Anyone noticed the old enemy, Conflicts of Interest, rearing its ugly head again?
Posted by
Willow
at
11:42 pm
Labels: Change4Life, conflicts of interest, Department of Health, Freudian Slip, Guardian article, Junk Food, KFC, Matthew Freud, Pepsi, public health, Walkers Crisps
Monday, November 14, 2011
Today is World Diabetes Day
Today, November 14th 2011, is World Diabetes Day. November 14th was the birthday of Sir Frederick Banting, the Nobel Laureate who, in 1922, discovered insulin. If you have diabetes, I believe you would find the following articles interesting:
Paleolithic diet much better for diabetics than conventional ‘diabetes diet’
Vitamin D has potential to combat Type 2 diabetes
Conflicts of interest rife in those setting diabetes and cholesterol guidelines
Posted by
Willow
at
3:31 pm
Labels: cholesterol, conflicts of interest, Diabetes, Frederick Banting, insulin, Paleolithic Diet, Type 2 Diabetes, Vitamin D, World Diabetes Day
Saturday, October 22, 2011
More about Conflicts of Interest within the Medical Profession
"In 1996, shortly after we began tracking the pharmaceutical industry, we spent time looking at obesity research and the latest diet pills. In doing so, we noticed that a panel that was assembled by the government to develop a guideline for the overweight known as the Body Mass Index. And it was populated by experts, nearly all of whom had a financial tie to a drugmaker selling or developing such pills. The finding, of course, was not all that new, but the practice continues, according to a new study in BMJ, which examined panels responsible for generating clinical practice guidelines on screening and/or treatment for high cholesterol or diabetes in the US and Canada between 2000 and 2010. A good many of the panelists - and panel chairs - had conflicts of interest. But not all were disclosed."
Read article at pharmalot.com
See also Dr Briffa's recent article on conflicts of interest.
Posted by
Willow
at
3:00 pm
Labels: BMJ, conflicts of interest, Diabetes, diet pills, high cholesterol, medical ethics, Obesity, Pharmaceutical industry, prescription drugs
Sunday, June 19, 2011
Private Finance Initiative contracts: File on 4 investigation
They are not guiltless, the gulls who played their parts in setting up these PFI deals decades ago. I urge you to visit the BBC webpage about this and listen to the File on 4 programme using iPlayer. "The Treasury is failing to monitor the "excessive" profits being made by the sale of PFI equity in the so-called "secondary" market, the BBC is told." Were the guys at the Treasury too dimwitted to be trusted with taxpayers' money or were they suffering from those infamous 'conflicts of interest' that are as near as dammit to bribes? - I know what I think, and I expect it's what you think too.
Posted by
Willow
at
8:07 pm
Labels: BBC Radio 4, conflicts of interest, File On 4, PFIs
Thursday, May 05, 2011
The medical drug-pushers are at it again: Wald still pressing for his polypills to be routinely prescribed to over-55s
Posted by
Willow
at
11:09 pm
Labels: blood pressure, cholesterol drug, conflicts of interest, heart disease, polypills, Sir Nicholas Wald, statins
Friday, April 22, 2011
Conflicts of interest and the drug companies
Major philanthropic foundations, such as the Bill & Melinda Gates Foundation, regularly make the news with their donations and initiatives aimed at improving global health. But there is an aspect to their efforts that may be overlooked - such organizations can have links with drugmakers that could constitute a conflict of interest, according to an analysis published in PLoS Medicine.
Read article at pharmalot.com
The Dr Rath Health Foundation comments: The PLoS analysis adds significantly to the information about the Gates Foundation that was published by the Los Angeles Times in January 2007. In particular, the researchers found that several members of the Gates Foundation’s management committee, leadership teams, affiliates, and major funders are currently or were previously members of the boards or executive branches of major drugmakers, including Merck and Novartis. To examine the commercial network of the Bill & Melinda Gates Foundation, click here and here. For further information about Bill Gates, click here.
Posted by
Willow
at
8:26 pm
Labels: Bill and Melinda Gates Foundation, conflicts of interest, drug companies, Health, Merck, Novartis
Wednesday, March 30, 2011
Unethical financial conflicts of interest dominated some panels of medics
Unethical financial conflicts of interest dominated some panels of medics who wrote guidelines on cardiovascular health in recent years. See NYTimes article.
Posted by
Willow
at
1:31 pm
Saturday, February 05, 2011
Government Ministers and possible conflicts of interest
There is a pretence that when UK government ministers put their financial investments into a blind trust this frees them from conflicts of interest in the decisions they make as ministers. (See Guardian report and the Comments beneath the report.) People who believe this nonsense, I suspect, spend quite a lot of their time away with the fairies... No doubt they also believe those members of the medical profession who claim that their financial ties to the pharmaceutical industry in no way influence their decisions about which drugs to prescribe/recommend?
Posted by
Willow
at
8:28 pm
Labels: away with the fairies, blind trusts, conflicts of interest
Friday, February 04, 2011
Leukaemia drug treatment research compromised by drug company funding and authors with potential conflicts of interest?
Three Australian oncologists say cancer treatment research published in one of the world's most prestigious medical journals may have been compromised by a drug company that funded the study. They said publication of the research in The Lancet might have boosted the drug's perceived value to doctors and patients around the world, helping its manufacturer, Roche, make billions of dollars from the product.
Read article in the Sydney Morning Herald (Australia)
Posted by
Willow
at
11:11 am
Labels: conflicts of interest, rituximab, Roche, The Lancet

